Navigation Links
Chemo for Mesothelioma Offers Limited Survival Benefits
Date:5/15/2008

Therapy does not appear to help quality of life for lung cancer linked to asbestos,,

THURSDAY, May 15 (HealthDay News) -- Adding chemotherapy to other treatments being giving to patients with mesothelioma, a lung cancer usually linked to asbestos exposure, does not appear to improve either survival or quality of life.

Malignant pleural mesothelioma (MPM), which is usually fatal, is a cancer of the protective lining that covers the lungs. Asbestos is still produced or used in large quantities in countries such as Russia, China, Canada, Kazakhstan, Brazil, Zimbabwe, India and Thailand.

In the study, published in this week's issue of The Lancet, groups of mesothelioma patients received one of two chemotherapy regimes (four cycles of mitomycin, vinblastine and cisplatin every three weeks or one injection of vinorelbine every week for 12 weeks) in addition to active symptom control (ACS) treatments. ACS can include steroids, painkillers, bronchodilators and palliative radiotherapy to control the cancer's symptoms. Another group only received the symptom control treatments.

At the time of the analysis, roughly 96 percent of patients in all three groups had died. Only a slight but statistically insignificant improvement in survival rates after one year was found when comparing the two chemotherapy groups combined to those receiving only treatment for symptoms (32 percent vs. 29 percent).

Patients in the chemotherapy group that received vinorelbine, though, did have a slightly better survival rate (37 percent) than the other two groups but, again, researchers said this was not statistically significant.

Quality-of-life scores (physical functioning, pain, shortness of breath, overall health status) were similar in the three groups.

"The addition of chemotherapy to ASC offers no significant benefits in terms of overall survival or quality of life. However, exploratory analyses suggested that vinorelbine merits further investigation," the authors concluded.

More information

The National Cancer Institute has more about mesothelioma.



-- Kevin McKeever



SOURCE: The Lancet, news release, May 15, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Targeted therapy plus chemotherapy may pack 1-2 punch against melanoma
2. Blacks not receiving chemotherapy for rectal cancer, despite seeing cancer specialists
3. Black Rectal Cancer Patients Less Likely to Get Chemo, Radiation
4. Chemotherapy causes delayed severe neural damage
5. Common Chemotherapy Drug Linked to Memory Problems
6. Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
7. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
8. High-Dose Chemo Fails Against Small Cell Lung Cancers
9. High-intensity chemotherapy does not improve survival in small cell lung cancer
10. Most Cancer Survivors Say Chemo Fears Unfounded
11. Fasting Before Chemo Protects Healthy Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent review ... as the number one company for hearing aids, ranking it higher ... other brands. ... Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, state-of-the-art, ...
Breaking Medicine Technology: